Anondita Medicare Receives Order for ₹2.92 Crore from Ministry of Health
Anondita Medicare Limited has secured a significant purchase order totaling ₹2,92,41,000/- from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India. The contract involves the supply of Condoms SMO (Ustad Nirodh-HLL) [363].The Purchase Order (PO No: 10282600139/PDI/Domestic Fund-DF), dated June 16, 2026, outlines the terms for the domestic supply of contraceptives. The order is structured in two tranches. Fifty percent of the total quantity must be executed within 60 days from the PO date. The remaining fifty percent is scheduled for execution between 61 and 120 days after the purchase order date.
The deal with the Government of India entity, Central Medical Services Society, marks a key business development for Anondita Medicare in this sector. According to the contract details, there is no interest from any promoter or promoter group company in the awarding entity, and the transaction has been confirmed as non-related party.
Key financial and operational aspects of the government order are summarized below:
| Detail | Specification |
|---|---|
| Awarding Entity | Central Medical Services Society, Ministry of Health and Family Welfare (Government of India) |
| Product Supplied | Condoms SMO (Ustad Nirodh-HLL) [363] |
| Order Value | ₹2,92,41,000/- |
| Execution Period | Two tranches: 50% within 60 days; remaining 50% between 61 and 120 days. |
| Transaction Type | Domestic supply to a domestic entity. |
ANONDITA Stock Price Movement
Anondita Medicare Limited shares edged higher on Tuesday, climbing 0.62% to settle at ₹1196.95. The stock saw a trading volume of 26,800 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.